Literature DB >> 11579687

[Phytotherapeutic aspects of diseases of the circulatory system. 8. Chinese magnolia (Schisandra chinensis (Turcz.) Baill.): production of the drugs and their evaluation, therapeutic and dietary preparations].

L Opletal1, M Krenková, P Havlícková.   

Abstract

Extracts from the fruits (seeds) of Schisandra chinensis L. and pure isolated substances are one of the components of medicinal preparations designed for the treatment of cardiovascular diseases, liver diseases, diseases of the CNS related to the old age, as a supplement in the treatment of neoplasms, diabetes, etc. They are also used for the production of nutraceuticals (soft drinks and health foods), preparations for oral hygiene and for the care for the skin and hair. The review discusses complex analytical methods used for the determination of the content of substances and the phenomena of population ecology in relation with drug production.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579687

Source DB:  PubMed          Journal:  Ceska Slov Farm        ISSN: 1210-7816


  2 in total

1.  Schizandra arisanensis extract attenuates cytokine-mediated cytotoxicity in insulin-secreting cells.

Authors:  Yi-Shin Hsu; Yao-Haur Kuo; Hui-Ling Cheng; Peter R Flatt; Hui-Kang Liu
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

2.  Schisandra chinensis peptidoglycan-assisted transmembrane transport of lignans uniquely altered the pharmacokinetic and pharmacodynamic mechanisms in human HepG2 cell model.

Authors:  Charng-Cherng Chyau; Yaw-Bee Ker; Chi-Huang Chang; Shiau-Huei Huang; Hui-Er Wang; Chiung-Chi Peng; Robert Y Peng
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.